Clinical Trial

Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction

Study acronym: Co-Boost
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 20, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training in individuals with cocaine use disorder. The main questions the investigators aim to answer are: * Can the investigators observe a positive, significant effect on percentage of cocaine use days of both interventions combined as well as stand alone interventions? * Is there a significant transfer effect of the neurofeedback training? * Is there a significant, ketamine-dependent change in glutamate levels in the nucleus accumbens? Participants will be given ketamine and a realtime fMRI neurofeedback training. Both interventions are placebo-controlled. The investigators will compare the four intervention groups to investigate the effects of the stand-alone effects of the intervention and the combination of it.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-06; most recent amendment 2024-12-17.
Status change: Not Yet Recruiting → Recruiting 2024-01-04
Trial Details
NCT Number NCT06125054
Lead Sponsor Dr. med. Marcus Herdener
Collaborators: University of Zurich, University of Vienna, University of Campania Luigi Vanvitelli
Conditions Cocaine Use Disorder, Cocaine Dependence
Enrollment 120 participants
Start Date 2024-02-05
Primary Completion 2025-12 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-12-20